Difference between revisions of "Team:Aalto-Helsinki/Laboratory Theory"

 
(18 intermediate revisions by 5 users not shown)
Line 8: Line 8:
 
   <div class="text1">LABORATORY</div>
 
   <div class="text1">LABORATORY</div>
 
   <div class="text2">
 
   <div class="text2">
 +
    <a href="https://2017.igem.org/Team:Aalto-Helsinki/Description">Overview</a><br>
 
     <a style="text-decoration: underline" href="https://2017.igem.org/Team:Aalto-Helsinki/Laboratory_Theory">Theoretical Background</a><br>
 
     <a style="text-decoration: underline" href="https://2017.igem.org/Team:Aalto-Helsinki/Laboratory_Theory">Theoretical Background</a><br>
 
     <a href="https://2017.igem.org/Team:Aalto-Helsinki/Experiments">Materials and Methods</a><br>
 
     <a href="https://2017.igem.org/Team:Aalto-Helsinki/Experiments">Materials and Methods</a><br>
 
     <a href="https://2017.igem.org/Team:Aalto-Helsinki/Protocols">Protocols</a><br>
 
     <a href="https://2017.igem.org/Team:Aalto-Helsinki/Protocols">Protocols</a><br>
 
     <a href="https://2017.igem.org/Team:Aalto-Helsinki/Results">Results and Discussion</a><br>
 
     <a href="https://2017.igem.org/Team:Aalto-Helsinki/Results">Results and Discussion</a><br>
     <a href="https://2017.igem.org/Team:Aalto-Helsinki/Laboratory_Future">Future Perspectives</a><br>
+
     <a href="https://2017.igem.org/Team:Aalto-Helsinki/Laboratory_Future">Future Perspectives</a>
<a href="https://2017.igem.org/Team:Aalto-Helsinki/Improve">Improve</a>
+
 
   </div>
 
   </div>
 
</span>  
 
</span>  
Line 26: Line 26:
 
<h4>Antimicrobial Peptides and Dermcidin</h4>
 
<h4>Antimicrobial Peptides and Dermcidin</h4>
 
<p id="paragraph">
 
<p id="paragraph">
New alternatives to antibiotics have been receiving great attention, with increasing threat of antibiotic resistant to commonly used antibiotics. Antimicrobial peptides emerge as a promising alternative due to their wide range of spectrum. Since the 70’s, several antimicrobial peptides from various species have discovered. Antimicrobial peptides are known for their important role in natural self-defense mechanism for many species, including bacteria, fungi and primates.
+
New alternatives to antibiotics have received great attention, with an increasing threat of antibiotic resistance to commonly used antibiotics. Antimicrobial peptides emerge as a promising alternative due to their wide range of spectrum. Since the 70’s, several antimicrobial peptides from various species have been discovered. Antimicrobial peptides are known for their important role in natural self-defense mechanism for many species, including bacteria, fungi, and primates.
 
</p>
 
</p>
  
 
<p id="paragraph">
 
<p id="paragraph">
Dermcidin is an antimicrobial peptide (AMP) found in primates with no homology to other know AMPs. (1) It is expressed in a constitutive manner in eccrine sweat glands and secreted to epidermal surface as a part of first line of defense. (2) Mature Dermcidin precursor is 110 amino acids long, including signal peptide. Once antimicrobial peptide precursor is secreted with sweat to epidermal surface, 19 amino acid long signal peptide is cleaved, and it goes under further proteolytic processing leading to several dermcidin derived peptides such as DCD1 and DCD1L. DCD1L is one of the most abundant form of dermcidin derived peptide. DCD1L is a 48-amino-acid long anionic peptide active against wide spectrum of bacteria including <i>Staphylococcus aureus</i>, <i>Escherichia coli</i>, and <i>Propionibacterium acnes</i>. (1,6) Also, dermcidin is evolved to survive and maintain its activity in harsh conditions that is in sweat.
+
Dermcidin is an antimicrobial peptide (AMP) found in primates with no homology to other know AMPs. <a name="ref1" href="#refl1">[1]</a> It is expressed in a constitutive manner in eccrine sweat glands and secreted to epidermal surface as a part of the first line of defense. <a name="ref2" href="#refl2">[2]</a> Mature dermcidin precursor is 110 amino acids long, including a signal peptide. Once the antimicrobial peptide precursor is secreted with sweat to the epidermal surface, the 19-amino-acid long signal peptide is cleaved, and it goes under further proteolytic processing leading to several dermcidin-derived peptides such as DCD1 and DCD-1L. DCD-1L is one of the most abundant forms of dermcidin-derived peptides. DCD-1L is a 48-amino-acid long anionic peptide active against a wide spectrum of bacteria including <i>Staphylococcus aureus</i>, <i>Escherichia coli</i>, and <i>Propionibacterium acnes</i>. [<a name="ref1" href="#refl1">1</a>, <a name="ref6" href="#refl6">6</a>] Also, dermcidin has evolved to survive and maintain its activity in the harsh conditions in sweat.
 +
</p>
 +
 
 +
<img style="width:50%;" src="https://static.igem.org/mediawiki/2017/a/a4/T--Aalto-Helsinki--dermcidin_hexamer_pore2.png">
 +
<p style="text-align: center" id="paragraph">
 +
<i>Figure 1. Visualization of a DCD-1L hexamer inserted in a membrane, forming a pore.</i>
 
</p>
 
</p>
  
 
<h4>Mode of Action</h4>
 
<h4>Mode of Action</h4>
 
<p id="paragraph">
 
<p id="paragraph">
Most AMPs are cationic, taking action by electrostatic interactions with negatively charged phospholipid bilayer of pathogens. Unlike other AMPs, DCD1L is anionic, giving it a different mode of action. Although the precise mode of action is not entirely explored, it is thought that[KME1]  forms pores on bacterial membrane leading to cell death. DCD1L has overall net charge -2 with cationic N-terminal region and anionic C-terminal region. N-terminal of DCD1L (1 to 23), first interacts with bacterial membrane initially and allows peptides placement on membrane surface, followed by formation of a hexameric pore that further stabilized by Zn+2 ions and under low pH sweat conditions. Also, the fact that DCD1L is amphipathic, supports alpha helix structure and insertion into phospholipid bilayer.     
+
Most AMPs are cationic, taking action by electrostatic interactions with the negatively charged phospholipid bilayer of pathogens. Unlike other AMPs, DCD-1L is anionic, giving it a different mode of action. Although the precise mode of action is not entirely explored, it is thought that DCD-1L forms pores in the bacterial membrane leading to cell death. DCD-1L has an overall net charge of -2 with a cationic N-terminal region and an anionic C-terminal region. The N-terminus of DCD-1L (amino acids 1 to 23), first interacts with the bacterial membrane and allows the placement of peptides on the membrane surface, followed by formation of a hexameric pore that is further stabilized by Zn<sup>2+</sup> ions and under low pH sweat conditions. Also, the fact that DCD-1L is amphipathic, supports the alpha helix structure and insertion into the phospholipid bilayer.     
 
</p>
 
</p>
 +
</div>
 +
</div>
  
 +
<div id="quote-block">
 +
<div class="quote-mark"><q></q></div>
 +
<div style="font-size: 25px !important;" class="quote-text">Antimicrobial peptides emerge as a promising alternative due to their wide range of spectrum.</div>
 +
</div>
 +
 +
<div class="container">
 +
<div class="basictext">
 
<h4>Heterologous Production of Dermcidin</h4>
 
<h4>Heterologous Production of Dermcidin</h4>
 
<p id="paragraph">
 
<p id="paragraph">
In many studies, chemically synthesized dermcidin peptides are used because of difficulties in recombinant expression caused by toxicity of peptide to expression host due to its antimicrobial nature. However, chemical synthesis is expensive, costing several hundreds for mg quantities. Therefore, production of the antimicrobial peptide in form of a fusion protein in a heterologous expression system is an important alternative to be exploited. In previous published methods, DCD-1 is produced recombinantly but to cleave off the fusion tag CNBr is used. (4) CNBr was not the most optimal method to be used not only due to its volatile and toxic nature, especially in safety level 1 premises, but also because of possible side reactions in the presence of serine and threonine following methionine. With perspective of safety, in our work, Ulp1 enzyme, known for its robust and specific proteolytic activity against SUMO fusion proteins, is utilized to cleave of Hisx6-Smt3 tag is used for expression and purification. (3) 6xHis tag in N-terminus is used for purification with immobilized metal ion affinity chromatography (IMAC) columns designed for histidine tagged proteins.
+
In many studies, chemically synthesized dermcidin peptides are used because of difficulties in the recombinant expression caused by toxicity of the peptide to the expression host due to its antimicrobial nature. However, chemical synthesis is expensive, costing several hundreds for mg quantities. Therefore, production of the antimicrobial peptide in the form of a fusion protein in a heterologous expression system is an important alternative to be exploited. In previously published methods, DCD-1 is produced recombinantly but CNBr is used to cleave off the fusion tag. <a name="ref3" href="#refl3">[3]</a> CNBr is not the most optimal method to use not only due to its volatile and toxic nature, especially in safety level 1 premises, but also because of possible side reactions in the presence of serine and threonine following methionine. With the perspective of safety, Ulp1 enzyme is utilized in our work to cleave off the His6x-Smt3 tag that is used in expression and purification. Ulp1 is known for its robust and specific proteolytic activity against SUMO fusion proteins, which makes this a promising system for recombinant protein production. <a name="ref4" href="#refl4">[4]</a> the His6x tag in the N-terminus is used for purification with immobilized metal ion affinity chromatography (IMAC) columns designed for histidine tagged proteins.
 
</p>
 
</p>
  
 
<p id="paragraph">
 
<p id="paragraph">
Employing of Smt3 tag is beneficial in several aspects in our project; to facilitate cleavage of fusion peptide, to keep antimicrobial peptide in inactivation form by blocking its adhesion due to relatively large size of His-Smt3 tag, and advantages due to SUMO tag is its effect on solubility and preventing inclusion bodies of fusion peptide significantly easing purification step. One other major advantage of the fusion system used is that it facilitated easier detect of the peptide with a conventional method, SDS-PAGE.  Our expression system is inducible with addition of isopropyl-&#946;-D-thiogalactopyranoside (IPTG) to expression culture, since IPTG induces T7 RNA polymerase promoter leading to expression of gene of interest in plasmid.
+
Employing the Smt3 tag is beneficial to our project in several aspects: it facilitates cleavage of the fusion peptide, it keeps the antimicrobial peptide in an inactive form by blocking its adhesion due to the relatively large size of His6x-Smt3 tag, and it eases the purification step due to the advantageous effects that the SUMO tag has on solubility, preventing the formation of inclusion bodies of the fusion peptides. One other major advantage of this fusion system is that it facilitates detection of the peptide with a conventional method, SDS-PAGE.  Our expression system is inducible with addition of isopropyl-&#946;-D-thiogalactopyranoside (IPTG) to the expression culture, since IPTG induces T7 RNA polymerase promoter leading to expression of the gene of interest in the plasmid.
 
</p>
 
</p>
  
 
<h4>Immobilization and CBM</h4>
 
<h4>Immobilization and CBM</h4>
 
<p id="paragraph">
 
<p id="paragraph">
Bacterial adhesion to surfaces and biofilm formation is one of the major reasons for spreading bacterial infections especially in public places such as hospital environment. Preventing pathogen colonization on surfaces in such environments, is crucial. Therefore, immobilization of antimicrobial peptides can be a good alternative to other bactericidal agents because of wide antibiotic spectrum of DCD1L given that immobilization is a known way of increasing stability and resilience of peptides. Thus, throughout our project one of our goals was to immobilize DCD1L as an antimicrobial coating agent. For this purpose, four different constructs are designed containing a cellulose binding domain (CBM3) from <i>Clostridium thermocellum</i>, to immobilize DCD1L on cellulose based materials.
+
Bacterial adhesion to surfaces and biofilm formation is one of the major reasons for spreading bacterial infections especially in public places, such as the hospital environment. Preventing pathogen colonization on surfaces in such environments is crucial. Therefore, immobilization of antimicrobial peptides can be a good alternative to other bactericidal agents because of the wide antibiotic spectrum of DCD-1L, given that immobilization is a known way of increasing stability and resilience of peptides. Thus, throughout our project one of our goals was to immobilize DCD-1L as an antimicrobial coating agent. For this purpose, four different constructs were designed containing a cellulose binding domain (CBM3) from <i>Clostridium thermocellum</i>, to immobilize DCD-1L on cellulose based materials.
 
</p>
 
</p>
  
 
<p id="paragraph">
 
<p id="paragraph">
Our CBM constructs contain 22 amino acid long linker, to avoid interference with hexameric complex formation that leads cell death. Although, after visits and discussions with healthcare professionals as a part of our integrated human practices efforts we altered the direction of our project to fight acne causing bacteria, <i>P. acnes</i>. We included cellulose to our project since we discovered versatile nature of cellulosic materials, expanding possible applications.
+
Our CBM constructs contain a 22-amino-acid long linker to avoid interference of CBM with hexameric complex formation of the antimicrobial peptides that leads to bacterial cell death. Although, after visits and discussions with healthcare professionals as part of our integrated human practices, we altered the direction of our project to fight acne causing bacteria, <i>P. acnes</i>. We included cellulose to our project since we discovered the versatile nature of cellulosic materials, expanding possible applications.
 +
</p>
 +
 
 +
<img style="width:60%;" src="https://static.igem.org/mediawiki/2017/c/c5/T--Aalto-Helsinki--immobilization.png">
 +
 
 +
<p style="text-align: center" id="paragraph">
 +
<i>Figure 2. Visualization of the function of dermcidin bound to cellulose. This image was made for the postcard collaboration which we participated in.</i>
 
</p>
 
</p>
  
 
<p id="paragraph">
 
<p id="paragraph">
Cellulose based materials can be used in various forms from plastic-like hard materials to hydrogels. Also, cellulose is a medically safe, ecofriendly, and abundant material, already present or can easily be incorporated in many applications. [KME2] (5) It is recently suggested that acne patients have lower expression of dermcidin, leading to progression of the skin condition. With the knowledge of DCD1L’s activity against <i>P. acnes</i>, acne causing bacteria, we designed an acne product containing DCD1L peptide with cellulose hydrogel aiming to combat <i>P. acnes</i>. (6)
+
Cellulose based materials can be used in various forms from plastic-like hard materials to hydrogels. Also, cellulose is a medically safe, ecofriendly, and abundant material that is already present or can easily be incorporated in many applications. <a name="ref5" href="#refl5">[5]</a> It was recently suggested that acne patients have lower expression of dermcidin, leading to progression of the skin condition. With the knowledge of DCD-1L’s activity against <i>P. acnes</i>, acne causing bacteria, we designed an acne product containing DCD-1L peptide with cellulose hydrogel aiming to combat <i>P. acnes</i>. <a name="ref6" href="#refl6">[6]</a>
 
You can read more from about the application from our <a href="https://2017.igem.org/Team:Aalto-Helsinki/Applied_Design">Applied design page</a>.
 
You can read more from about the application from our <a href="https://2017.igem.org/Team:Aalto-Helsinki/Applied_Design">Applied design page</a>.
 
</p>
 
</p>
Line 73: Line 93:
 
<h3>References</h3>
 
<h3>References</h3>
 
<p id="paragraph">
 
<p id="paragraph">
<a name="refl1" href="#ref1">[1]</a> Writers, YEAR. <i>Name of article / book.</i> Publication. Accessible at: [url here].<br>
+
<a name="refl1" href="#ref1">[1]</a> Schittek, B., Hipfel, R., Sauer, B., Bauer, J., Kalbacher, H., Stevanovic, S., ... & Rassner, G. (2001). Dermcidin: a novel human antibiotic peptide secreted by sweat glands. <I>Nature immunology, 2</I>(12), 1133-1137.<br>
<a name="refl2" href="#ref2">[2]</a> Writers, YEAR. <i>Name of article / book.</i> Publication. Accessible at: [url here].<br>
+
<a name="refl2" href="#ref2">[2]</a> Burian, M., & Schittek, B. (2015). The secrets of dermcidin action. <I>International Journal of Medical Microbiology, 305</I>(2), 283-286.<br>
[3] Writers, YEAR. <i>Name of article / book.</i> Publication. Accessible at: [url here].<br>
+
<a name="refl3" href="#ref3">[3]</a> Cipáková, I., Gasperík, J., & Hostinová, E. (2006). Expression and purification of human antimicrobial peptide, dermcidin, in Escherichia coli. <I>Protein expression and purification, 45</I>(2), 269-274.5)<br>
[4] Writers, YEAR. <i>Name of article / book.</i> Publication. Accessible at: [url here].<br>
+
<a name="refl4" href="#ref4">[4]</a> Malakhov, M. P., Mattern, M. R., Malakhova, O. A., Drinker, M., Weeks, S. D., & Butt, T. R. (2004). SUMO fusions and SUMO-specific protease for efficient expression and purification of proteins. <I>Journal of structural and functional genomics, 5</I>(1), 75-86.<br>
[5] Writers, YEAR. <i>Name of article / book.</i> Publication. Accessible at: [url here].<br>
+
<a name="refl5" href="#ref5">[5]</a> Ng, V. W., Chan, J. M., Sardon, H., Ono, R. J., García, J. M., Yang, Y. Y., & Hedrick, J. L. (2014). Antimicrobial hydrogels: a new weapon in the arsenal against multidrug-resistant infections. <I>Advanced drug delivery reviews, 78</I>, 46-62.<br>
 +
<a name="refl6" href="#ref6">[6]</a> Nakano, T., Yoshino, T., Fujimura, T., Arai, S., Mukuno, A., Sato, N., & Katsuoka, K. (2015). Reduced expression of dermcidin, a peptide active against Propionibacterium acnes, in sweat of patients with acne vulgaris. <I>Acta dermato-venereologica, 95</I>(7), 783-786.<br>  
 
</p>
 
</p>
 
</div>
 
</div>

Latest revision as of 09:20, 1 November 2017

Aalto-Helsinki




Theoretical Background

Antimicrobial Peptides and Dermcidin

New alternatives to antibiotics have received great attention, with an increasing threat of antibiotic resistance to commonly used antibiotics. Antimicrobial peptides emerge as a promising alternative due to their wide range of spectrum. Since the 70’s, several antimicrobial peptides from various species have been discovered. Antimicrobial peptides are known for their important role in natural self-defense mechanism for many species, including bacteria, fungi, and primates.

Dermcidin is an antimicrobial peptide (AMP) found in primates with no homology to other know AMPs. [1] It is expressed in a constitutive manner in eccrine sweat glands and secreted to epidermal surface as a part of the first line of defense. [2] Mature dermcidin precursor is 110 amino acids long, including a signal peptide. Once the antimicrobial peptide precursor is secreted with sweat to the epidermal surface, the 19-amino-acid long signal peptide is cleaved, and it goes under further proteolytic processing leading to several dermcidin-derived peptides such as DCD1 and DCD-1L. DCD-1L is one of the most abundant forms of dermcidin-derived peptides. DCD-1L is a 48-amino-acid long anionic peptide active against a wide spectrum of bacteria including Staphylococcus aureus, Escherichia coli, and Propionibacterium acnes. [1, 6] Also, dermcidin has evolved to survive and maintain its activity in the harsh conditions in sweat.

Figure 1. Visualization of a DCD-1L hexamer inserted in a membrane, forming a pore.

Mode of Action

Most AMPs are cationic, taking action by electrostatic interactions with the negatively charged phospholipid bilayer of pathogens. Unlike other AMPs, DCD-1L is anionic, giving it a different mode of action. Although the precise mode of action is not entirely explored, it is thought that DCD-1L forms pores in the bacterial membrane leading to cell death. DCD-1L has an overall net charge of -2 with a cationic N-terminal region and an anionic C-terminal region. The N-terminus of DCD-1L (amino acids 1 to 23), first interacts with the bacterial membrane and allows the placement of peptides on the membrane surface, followed by formation of a hexameric pore that is further stabilized by Zn2+ ions and under low pH sweat conditions. Also, the fact that DCD-1L is amphipathic, supports the alpha helix structure and insertion into the phospholipid bilayer.

Antimicrobial peptides emerge as a promising alternative due to their wide range of spectrum.

Heterologous Production of Dermcidin

In many studies, chemically synthesized dermcidin peptides are used because of difficulties in the recombinant expression caused by toxicity of the peptide to the expression host due to its antimicrobial nature. However, chemical synthesis is expensive, costing several hundreds for mg quantities. Therefore, production of the antimicrobial peptide in the form of a fusion protein in a heterologous expression system is an important alternative to be exploited. In previously published methods, DCD-1 is produced recombinantly but CNBr is used to cleave off the fusion tag. [3] CNBr is not the most optimal method to use not only due to its volatile and toxic nature, especially in safety level 1 premises, but also because of possible side reactions in the presence of serine and threonine following methionine. With the perspective of safety, Ulp1 enzyme is utilized in our work to cleave off the His6x-Smt3 tag that is used in expression and purification. Ulp1 is known for its robust and specific proteolytic activity against SUMO fusion proteins, which makes this a promising system for recombinant protein production. [4] the His6x tag in the N-terminus is used for purification with immobilized metal ion affinity chromatography (IMAC) columns designed for histidine tagged proteins.

Employing the Smt3 tag is beneficial to our project in several aspects: it facilitates cleavage of the fusion peptide, it keeps the antimicrobial peptide in an inactive form by blocking its adhesion due to the relatively large size of His6x-Smt3 tag, and it eases the purification step due to the advantageous effects that the SUMO tag has on solubility, preventing the formation of inclusion bodies of the fusion peptides. One other major advantage of this fusion system is that it facilitates detection of the peptide with a conventional method, SDS-PAGE. Our expression system is inducible with addition of isopropyl-β-D-thiogalactopyranoside (IPTG) to the expression culture, since IPTG induces T7 RNA polymerase promoter leading to expression of the gene of interest in the plasmid.

Immobilization and CBM

Bacterial adhesion to surfaces and biofilm formation is one of the major reasons for spreading bacterial infections especially in public places, such as the hospital environment. Preventing pathogen colonization on surfaces in such environments is crucial. Therefore, immobilization of antimicrobial peptides can be a good alternative to other bactericidal agents because of the wide antibiotic spectrum of DCD-1L, given that immobilization is a known way of increasing stability and resilience of peptides. Thus, throughout our project one of our goals was to immobilize DCD-1L as an antimicrobial coating agent. For this purpose, four different constructs were designed containing a cellulose binding domain (CBM3) from Clostridium thermocellum, to immobilize DCD-1L on cellulose based materials.

Our CBM constructs contain a 22-amino-acid long linker to avoid interference of CBM with hexameric complex formation of the antimicrobial peptides that leads to bacterial cell death. Although, after visits and discussions with healthcare professionals as part of our integrated human practices, we altered the direction of our project to fight acne causing bacteria, P. acnes. We included cellulose to our project since we discovered the versatile nature of cellulosic materials, expanding possible applications.

Figure 2. Visualization of the function of dermcidin bound to cellulose. This image was made for the postcard collaboration which we participated in.

Cellulose based materials can be used in various forms from plastic-like hard materials to hydrogels. Also, cellulose is a medically safe, ecofriendly, and abundant material that is already present or can easily be incorporated in many applications. [5] It was recently suggested that acne patients have lower expression of dermcidin, leading to progression of the skin condition. With the knowledge of DCD-1L’s activity against P. acnes, acne causing bacteria, we designed an acne product containing DCD-1L peptide with cellulose hydrogel aiming to combat P. acnes. [6] You can read more from about the application from our Applied design page.

References

[1] Schittek, B., Hipfel, R., Sauer, B., Bauer, J., Kalbacher, H., Stevanovic, S., ... & Rassner, G. (2001). Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nature immunology, 2(12), 1133-1137.
[2] Burian, M., & Schittek, B. (2015). The secrets of dermcidin action. International Journal of Medical Microbiology, 305(2), 283-286.
[3] Cipáková, I., Gasperík, J., & Hostinová, E. (2006). Expression and purification of human antimicrobial peptide, dermcidin, in Escherichia coli. Protein expression and purification, 45(2), 269-274.5)
[4] Malakhov, M. P., Mattern, M. R., Malakhova, O. A., Drinker, M., Weeks, S. D., & Butt, T. R. (2004). SUMO fusions and SUMO-specific protease for efficient expression and purification of proteins. Journal of structural and functional genomics, 5(1), 75-86.
[5] Ng, V. W., Chan, J. M., Sardon, H., Ono, R. J., García, J. M., Yang, Y. Y., & Hedrick, J. L. (2014). Antimicrobial hydrogels: a new weapon in the arsenal against multidrug-resistant infections. Advanced drug delivery reviews, 78, 46-62.
[6] Nakano, T., Yoshino, T., Fujimura, T., Arai, S., Mukuno, A., Sato, N., & Katsuoka, K. (2015). Reduced expression of dermcidin, a peptide active against Propionibacterium acnes, in sweat of patients with acne vulgaris. Acta dermato-venereologica, 95(7), 783-786.